Cardiac-specific overexpression of DGKζ has been reported to prevent angiotensin II- and phenylepinephrine-induced activation of several PKCs and subsequent cardiac hypertrophy [16]. The gene discussed is DGKZ; the disease is cardiac hypertrophy.